2011
DOI: 10.1016/j.biomaterials.2011.01.059
|View full text |Cite
|
Sign up to set email alerts
|

A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(11 citation statements)
references
References 39 publications
0
10
0
1
Order By: Relevance
“…29 Most cationic systems used to deliver nucleic acids to cells present a protection pattern to siRNA that is consistent with the amount of the cationic moiety employed to formulate the complexes, increasing from the lowest to the highest charge ratios. 30,31 However, the thermoresponsive copolymers studied herein did not present such behavior. Apparently, the polymer/ siRNA charge ratio did not affect the release of the siRNAs or showed an opposite effect to that described for nonthermoresponsive systems (Figure 4).…”
Section: Molecular Pharmaceuticsmentioning
confidence: 67%
“…29 Most cationic systems used to deliver nucleic acids to cells present a protection pattern to siRNA that is consistent with the amount of the cationic moiety employed to formulate the complexes, increasing from the lowest to the highest charge ratios. 30,31 However, the thermoresponsive copolymers studied herein did not present such behavior. Apparently, the polymer/ siRNA charge ratio did not affect the release of the siRNAs or showed an opposite effect to that described for nonthermoresponsive systems (Figure 4).…”
Section: Molecular Pharmaceuticsmentioning
confidence: 67%
“…Liposomes versatile and flexible system protection of the siRNA targeting possible membrane fusion and triggered drug release form aggregates with serum proteins immunogenic limited delivery efficiency in vivo [63] PEGylation decreased blood clearence [64] incorporation of fusogenic lipids enhanced bioavailability of siRNA [65] apolipoprotein A 95% knockdown without immunotoxicity targeted to the liver [66] pH-sensitive histidinelysine peptide inhibition of tumor growth in a pancreatic cancer model [67] peptide from Rabies Virus glycoprotein brain targeting [68] SNALPs -Stabilized Nucleic Acid Lipid Particles PEG-derivatized cationic lipid with stabilized lipid bilayer fusogenic prolonged blood circulation 80-90% efficiency after siRNA transfection into liver [34] SPANosomes sorbitan monooleate high siRNA incorporation efficiency efficient endosomal escape and cytosolic delivery 60-80% gene knockdown [69,70] Polyethylenimine -PEI toxicity of high molecular weight PEI proton sponge effect for efficient release from endosomes [21] hydrophobic lipid anchor improved cellular uptake [71] folate folate receptor mediated uptake [42] galactose and pullulan liver targeted [43,72] PEI-PEG-copolymer efficient siRNA release 75%gene knockdown efficiency suppression of tumor growth [73] bioreducible poly(amido ethylenimine) (SS-PAEI) complete release of siRNA in a reductive environment [62] Poly(dl-lactide-co-glycolide) -PLGA degraded under physiological conditions degradation rate can be controlled by composition of the polymer nucleic acid encapsulation no endosomal escape mechanism [74] cationic segments (polyamines) good binding and protections of siRNA disruption of endosomal membranes [75] poly(ethylene glycol)-poly (d,l-lactide) cationic lipic suppressed tumor growth in a breast cancer murine xenograft model [76] Chitosan biodegradable, no/low immunogenicity low siRNA transfection efficiency [77,78] salt complexes excellent cell survival high gene silencing [79] α-tocopherol succinate enhanced cellular uptake [47] thiamine pyrophosphate >70% gene silencing [80] RGD peptide targeting to cancer cells [44] guanidinylation decreased cytotoxicity and enhanced cellular internalization of siRNA enhanced gene-silencing efficiency …”
Section: Sirna Delivery System Examples For Modifications Characterismentioning
confidence: 99%
“…As also discussed in the literature, polyethylenimines have been the most widely used vectors for such purposes in vitro and in vivo. 1217 Branched polyethylenimine (bPEI, 25 kDa), which consists of 1°, 2°, and 3° amines in the ratio of 1:2:1, displays high transfection efficiency but exhibits high toxicity due to high charge density. On the contrary, linear polyethylenimine (lPEI, 25 kDa) is a nontoxic polymer but exhibits poor transfection activity due to inefficient binding of nucleic acids.…”
Section: Introductionmentioning
confidence: 99%